PFSA$0.635-2.46%
Profusa, Inc.
Sector: Surgical & Medical Instruments & ApparatusIndustry: Medical - DevicesCountry: USExchange: Nasdaq
Mkt Cap:$384.6K
Float & O/S:
Inst Own:
DilutionScan read 55 of Profusa, Inc.'s SEC filings and found 7 warrant series, 18 convertibles, 1 equity line, 6 S-1 registrations and 8 completed offerings on file for PFSA. The latest dilution event on file is an offering on Oct 15, 2026. Analysis updated Oct 24, 2026.
Signal8 Summary
PFSA
Distressed micro-cap with exhausted cash
Snapshot
Profusa is a distressed micro-cap with zero revenue and a balance sheet under severe pressure. The business posted a $35.8M net loss in FY 2025 and burned $16.3M in free cash flow.
What's Happening Right Now
- : Profusa filed for a 1-for-4 reverse stock split effective August 17, 2026 to maintain its Nasdaq listing.
- : Profusa signed an option agreement to acquire G3 Vision Labs, a diagnostics company with estimated 2025 net revenues of $111 million.
